Clinical Trial Update: QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for QUILT-2.019, a Phase 1/2 study of AMG-655 or AMG-479 with gemcitabine for metastatic pancreatic cancer, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AMG 479
• AMG 655 (AMG-655)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: NantCell, Inc. | Conditions: Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-17